All Stories

  1. Associations between demographic, clinical and dietary factors and flares in inflammatory bowel disease: the PRognostic effect of Environmental factors in Crohn’s and Colitis (PREdiCCt) prospective cohort study

    Article • Gut, January 2026, BMJ

    Charles Murray

  2. Clinical utility of pre-treatment four-digit-resolution HLA genotyping to guide anti-tumor necrosis factor choice and concomitant immunomodulator use

    Article • Journal of Crohn s and Colitis, December 2025, Oxford University Press (OUP)

    Charles Murray

  3. Delivering a Modified Mindfulness Based Stress Reduction Intervention for Inflammatory Bowel Disease in Adolescents and Young Adults: Assessing Feasibility, Acceptability, and Effectiveness

    Article • Clinical Child Psychology and Psychiatry, December 2025, SAGE Publications

    Charles Murray

  4. Zenker peroral endoscopic myotomy (Z-POEM) is safe and effective for the management of pharyngeal pouch: a multicentre retrospective cohort study

    Article • Digestive Diseases, June 2025, Karger Publishers

    Charles Murray

  5. Endoscopic Suturing for Defect Closure in the Upper Gastrointestinal Tract: A Retrospective Cohort Study

    Article • Gastrointestinal Disorders, April 2025, MDPI AG

    Charles Murray

  6. Targeted screening of at-risk patients with chronic heartburn using a non-endoscopic capsule sponge device can enhance the detection of Barrett’s oesophagus

    Article • Frontline Gastroenterology, December 2024, BMJ

    Charles Murray

  7. Systemic sclerosis–related fecal incontinence: a scoping review focusing on a neglected manifestation

    Article • Rheumatology, December 2024, Oxford University Press (OUP)

    Charles Murray

  8. A multimodal endoscopic approach for esophageal fistula closure

    Article • Endoscopy, November 2024, Thieme Publishing Group

    Charles Murray

  9. The A to Z of Peroral Endoscopic Myotomy

    Article • Journal of Clinical Gastroenterology, October 2024, Wolters Kluwer Health

    Charles Murray

  10. The safety and efficacy of endoscopic approaches for the management of Zenker’s diverticulum: a multicentre retrospective study

    Article • Surgical Endoscopy, August 2024, Springer Science + Business Media

    Charles Murray

  11. A disease-associated gene desert directs macrophage inflammation through ETS2

    Article • Nature, June 2024, Springer Science + Business Media

    Charles Murray

  12. Endoscopic suturing and clipping devices for defects in the GI tract

    Article • Best Practice & Research Clinical Gastroenterology, June 2024, Elsevier

    Charles Murray

  13. A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial

    Article • The Lancet Gastroenterology & Hepatology, May 2024, Elsevier

    Charles Murray

  14. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

    Article • The Lancet Gastroenterology & Hepatology, April 2024, Elsevier

    Charles Murray

  15. Role of oesophageal balloon cryoablation in combination with personalised immunotherapy to achieve luminal control in metastatic oesophageal cancer: a case report

    Article • Frontline Gastroenterology, March 2024, BMJ

    Charles Murray

  16. The endoscopic management of oesophageal strictures

    Article • Best Practice & Research Clinical Gastroenterology, March 2024, Elsevier

    Charles Murray

  17. Metabolic Endoscopy: Should Gastroenterologists Be Treating Type 2 Diabetes?

    Article • Gastrointestinal Disorders, February 2024, MDPI AG

    Charles Murray

  18. Peroral endoscopic myotomy for the management of symptomatic cricopharyngeal bar (C-POEM): a case series and video demonstration

    Article • Annals of Gastroenterology, January 2024, Hellenic Society of Gastroenterology

    Charles Murray

  19. Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource

    Article • Journal of Crohn s and Colitis, December 2023, Oxford University Press (OUP)

    Charles Murray

  20. Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients

    Article • Journal of Crohn s and Colitis, September 2023, Oxford University Press (OUP)

    Charles Murray

  21. Symptomatic duodenal metastasis from a small cell lung cancer primary: a rare case

    Article • Frontline Gastroenterology, September 2023, BMJ

    Charles Murray

  22. Metabolic and Bariatric Endoscopy: A Mini-Review

    Article • Life, September 2023, MDPI AG

    Charles Murray

  23. Management of a large percutaneous endoscopic gastrostomy tube-associated gastric ulcer with endoscopic suturing

    Article • Endoscopy, August 2023, Thieme Publishing Group

    Charles Murray

  24. Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom

    Article • Inflammatory Bowel Diseases, August 2023, Oxford University Press (OUP)

    Charles Murray

  25. Anti-TNF Biologicals Enhance the Anti-Inflammatory Properties of IgG N-Glycome in Crohn’s Disease

    Article • Biomolecules, June 2023, MDPI AG

    Charles Murray

  26. A disease-associated gene desert orchestrates macrophage inflammatory responses via ETS2

    Article • May 2023, Cold Spring Harbor Laboratory Press

    Charles Murray

  27. Phenome-Wide Association Study of Drugs and Co-morbidities Associated with Gastrointestinal Dysfunction in Systemic Sclerosis

    Article • The Journal of Rheumatology, February 2023, The Journal of Rheumatology

    Charles Murray

  28. Genome-Wide Methylation Profiling in 229 Patients With Crohn’s Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn’s Disease (TOPPIC)

    Article • Cellular and Molecular Gastroenterology and Hepatology, January 2023, Elsevier

    Charles Murray

  29. Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a pr...

    Article • The Lancet Gastroenterology & Hepatology, December 2022, Elsevier

    Charles Murray

  30. Between progress and changing times: The journey of UEG Education Committee's chair

    Article • United European Gastroenterology Journal, December 2022, Wiley

    Charles Murray

  31. Treatment adaptations and outcomes of patients experiencing inflammatory bowel disease flares during the early COVID ‐19 pandemic: the PREPARE‐IBD multicentre cohort study

    Article • Alimentary Pharmacology & Therapeutics, October 2022, Wiley

    Charles Murray

  32. Blood and guts

    Article • Gut, August 2022, BMJ

    Charles Murray

  33. Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease

    Article • The Lancet Rheumatology, July 2022, Elsevier

    Charles Murray

  34. Diagnostic Performance of Magnetic Resonance Enterography Disease Activity Indices Compared with a Histological Reference Standard for Adult Terminal Ileal Crohn’s Disease: Experience from the METRIC Trial

    Article • Journal of Crohn s and Colitis, June 2022, Oxford University Press (OUP)

    Charles Murray

  35. Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

    Article • Nature Communications, March 2022, Springer Science + Business Media

    Charles Murray

  36. Comparative effectiveness of a second-line biologic in patients with ulcerative colitis: vedolizumab followed by an anti-TNF versus anti-TNF followed by vedolizumab

    Article • Frontline Gastroenterology, January 2022, BMJ

    Charles Murray

  37. Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients

    Article • November 2021, Cold Spring Harbor Laboratory Press

    Charles Murray

  38. The Relationship Between Mucosal Microbiota, Colitis, and Systemic Inflammation in Chronic Granulomatous Disorder

    Article • Journal of Clinical Immunology, November 2021, Springer Science + Business Media

    Charles Murray

  39. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

    Article • The Lancet Gastroenterology & Hepatology, November 2021, Elsevier

    Charles Murray

  40. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

    Article • The Lancet Gastroenterology & Hepatology, November 2021, Elsevier

    Charles Murray, MD. PhD. Carlos Taxonera

  41. PMO-29 Switching between infliximab biosimilars: experience from two inflammatory bowel disease centres

    Article • November 2021, BMJ

    Charles Murray

  42. Benefits of Structured Pediatric to Adult Transition in Inflammatory Bowel Disease

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 2021, Wolters Kluwer Health

    Charles Murray

  43. Covid-19 vaccine-induced antibodies are attenuated and decay rapidly in infliximab treated patients

    Article • July 2021, Research Square

    Charles Murray

  44. The relationship between mucosal microbiota, colitis and systemic inflammation in Chronic Granulomatous Disorder

    Article • July 2021, Cold Spring Harbor Laboratory Press

    Charles Murray

  45. Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis

    Article • Rheumatology, April 2021, Oxford University Press (OUP)

    Charles Murray

  46. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab

    Article • Gut, March 2021, BMJ

    Charles Murray

  47. Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study

    Article • The Lancet Gastroenterology & Hepatology, February 2021, Elsevier

    Charles Murray

  48. Endoscopy during the peak of COVID-19 pandemic: impact on activity and financial implications for a tertiary referral center in London

    Article • Annals of Gastroenterology, January 2021, Hellenic Society of Gastroenterology

    Charles Murray

  49. Editorial: fatigue—difficult to assess and difficult to treat

    Article • Alimentary Pharmacology & Therapeutics, December 2020, Wiley

    Charles Murray

  50. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn’s disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource

    Article • Gut, October 2020, BMJ

    Charles Murray

  51. UEG Guidelines framework to guide clinical practice

    Article • United European Gastroenterology Journal, September 2020, SAGE Publications

    Charles Murray

  52. Organisational changes and challenges for inflammatory bowel disease services in the UK during the COVID-19 pandemic

    Article • Frontline Gastroenterology, June 2020, BMJ

    Charles Murray

  53. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel

    Article • Gut, June 2020, BMJ

    Charles Murray

  54. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic

    Article • Gut, April 2020, BMJ

    Charles Murray

  55. The cost-effectiveness of radiofrequency ablation for treating patients with gastric antral vascular ectasia refractory to first line endoscopic therapy

    Article • Current Medical Research and Opinion, March 2020, Taylor & Francis

    Charles Murray

  56. UEG Education—building on success

    Article • United European Gastroenterology Journal, February 2020, SAGE Publications

    Charles Murray

  57. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

    Article • Gastroenterology, January 2020, Elsevier

    Charles Murray

  58. Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice

    Article • Frontline Gastroenterology, September 2019, BMJ

    Julian Walters, Charles Murray

  59. Magnetic resonance enterography compared with ultrasonography in newly diagnosed and relapsing Crohn’s disease patients: the METRIC diagnostic accuracy study

    Article • Health Technology Assessment, August 2019, National Institute for Health Research

    Charles Murray

  60. IBD BioResource: an open-access platform of 25 000 patients to accelerate research in Crohn’s and Colitis

    Article • Gut, July 2019, BMJ

    Charles Murray

  61. Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level

    Article • Journal of Clinical Immunology, June 2019, Springer Science + Business Media

    Charles Murray

  62. Editorial: combination immunosuppressive therapy to treat Crohn’s disease - ready for all age groups?

    Article • Alimentary Pharmacology & Therapeutics, May 2019, Wiley

    Charles Murray

  63. Radiological findings in gastrointestinal scleroderma

    Article • Journal of Scleroderma and Related Disorders, May 2019, SAGE Publications

    Charles Murray

  64. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

    Article • The Lancet Gastroenterology & Hepatology, May 2019, Elsevier

    Charles Murray, Dr Kevin J Monahan

  65. Cause or effect? Interpreting emerging evidence for dysbiosis in systemic sclerosis

    Article • March 2019, Springer Science + Business Media

    Charles Murray

  66. Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease

    Article • JAMA, February 2019, American Medical Association (AMA)

    Charles Murray

  67. Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia

    Article • United European Gastroenterology Journal, November 2018, SAGE Publications

    Charles Murray

  68. In memory of Dr Tomer Adar

    Article • United European Gastroenterology Journal, October 2018, SAGE Publications

    Charles Murray

  69. A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population

    Article • Digestive Diseases and Sciences, September 2018, Springer Science + Business Media

    Charles Murray

  70. Rare coding variant analysis in a large cohort of Ashkenazi Jewish families with inflammatory bowel disease

    Article • Human Genetics, August 2018, Springer Science + Business Media

    Charles Murray

  71. Magnetic resonance enterography, small bowel ultrasound and colonoscopy to diagnose and stage Crohn’s disease: patient acceptability and perceived burden

    Article • European Radiology, August 2018, Springer Science + Business Media

    Charles Murray

  72. Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial

    Article • The Lancet Gastroenterology & Hepatology, August 2018, Elsevier

    Charles Murray

  73. A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

    Article • Inflammatory Bowel Diseases, March 2018, Oxford University Press (OUP)

    Charles Murray

  74. Editorial: anti-TNF therapy and myopenia in Crohn's disease-another step towards personalised medicine

    Article • Alimentary Pharmacology & Therapeutics, December 2017, Wiley

    Charles Murray

  75. There is a need for new systemic sclerosis subset criteria. A content analytic approach

    Article • Scandinavian Journal of Rheumatology, October 2017, Taylor & Francis

    Charles Murray, Frank Wollheim

  76. PTH-041 Definitive management of a very rare cause of significant acute upper gastrointestinal bleeding: gastric lipoma resected by hybrid endoscopic submucosal dissection

    Article • June 2017, BMJ

    Charles Murray

  77. PTH-054 Endoscopic submucosal dissection (esd) of gastric and rectal neuroendocrine tumours (nets): a case series from a tertiary referral centre (with video)

    Article • June 2017, BMJ

    Charles Murray

  78. AODTU-001 Radiofrequency ablation in patients with symptomatic anaemia secondary to gastric antral vascular ectasia

    Article • June 2017, BMJ

    Charles Murray

  79. UK guideline on transition of adolescent and young persons with chronic digestive diseases from paediatric to adult care

    Article • Gut, February 2017, BMJ

    Charles Murray

  80. Small bowel obstruction caused by a migrated Obalon gastric bariatric balloon: nonsurgical management by antegrade double-balloon panenteroscopy

    Article • Endoscopy, January 2017, Thieme Publishing Group

    Charles Murray

  81. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

    Article • The Lancet Gastroenterology & Hepatology, December 2016, Elsevier

    Charles Murray

  82. The role of dietary supplements in inflammatory bowel disease

    Article • European Journal of Gastroenterology & Hepatology, December 2016, Wolters Kluwer Health

    Charles Murray

  83. Small and Large Intestinal Involvement and Nutritional Issues

    Article • November 2016, Springer Science + Business Media

    Charles Murray

  84. Gallstone mimicry: a rare cause of abdominal pain

    Article • Gut, September 2016, BMJ

    Charles Murray

  85. Gastrointestinal manifestations of systemic sclerosis

    Article • Journal of Scleroderma and Related Disorders, September 2016, SAGE Publications

    Charles Murray

  86. The ABC of E-learning: Utilizing E-learning resources for training and research in gastroenterology

    Article • United European Gastroenterology Journal, July 2016, SAGE Publications

    Charles Murray

  87. Elevated liver enzymes in inflammatory bowel disease

    Article • European Journal of Gastroenterology & Hepatology, July 2016, Wolters Kluwer Health

    Prof james O'Beirne, Charles Murray

  88. Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis

    Article • Alimentary Pharmacology & Therapeutics, February 2016, Wiley

    Charles Murray

  89. P.14.3 CORRELATION BETWEEN CLINICAL RESPONSE AND ANEMIA RESOLUTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNF INHIBITORS

    Article • Digestive and Liver Disease, February 2016, Elsevier

    Charles Murray

  90. Endoscopic resection of a giant ileal inflammatory fibroid polyp by retrograde double-balloon enteroscopy

    Article • Endoscopy, January 2016, Thieme Publishing Group

    Charles Murray

  91. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease

    Article • Journal of Crohn s and Colitis, November 2015, Oxford University Press (OUP)

    Charles Murray

  92. Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and rectal reservoirs

    Article • eLife, October 2015, eLife

    Charles Murray

  93. OP-16 DIETARY INTERVENTION USING THE LOW FODMAP DIET VERSUS THE “MILK, EGG, WHEAT AND SOYA FREE” DIET FOR TREATMENT OF FUNCTIONAL GUT DISORDERS A SINGLE CENTRE EXPERIENCE

    Article • Journal of Pediatric Gastroenterology and Nutrition, October 2015, Wolters Kluwer Health

    Charles Murray

  94. Gastro-oesophageal dismotility measurements in scleroderma-associated interstitial lung disease: Correlation with respiratory and reflux symptoms

    Article • September 2015, European Respiratory Society (ERS)

    Charles Murray

  95. Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis

    Article • Rheumatology, August 2015, Oxford University Press (OUP)

    Charles Murray

  96. Intractable diarrhoea despite immune reconstitution in an HIV positive man

    Article • Journal of Clinical Virology, August 2015, Elsevier

    Charles Murray

  97. UEG E‐learning: The future has arrived

    Article • United European Gastroenterology Journal, August 2015, Wiley

    Charles Murray

  98. Indurated plaques on the penis

    Article • Clinical and Experimental Dermatology, July 2015, Wiley

    Dr Shaaira Nasir, Charles Murray

  99. Gut symptoms in diabetics correlate with components of the rectoanal inhibitory reflex, but not with pudendal nerve motor latencies or systemic autonomic neuropathy

    Article • Journal of Digestive Diseases, June 2015, Wiley

    Charles Murray

  100. PTH-056 Trial to assess cannabidiol in the symptomatic treatment of ulcerative colitis

    Article • Gut, June 2015, BMJ

    Charles Murray

  101. Hepatic portal venous gas and portal venous thrombosis following colonoscopy in a patient with terminal ileal Crohn's disease

    Article • BMJ Case Reports, May 2015, BMJ

    Charles Murray

  102. Irritable bowel syndrome

    Article • Medicine, May 2015, Elsevier

    Charles Murray

  103. Travel health and pretravel preparation in the patient with inflammatory bowel disease

    Article • Frontline Gastroenterology, April 2015, BMJ

    Charles Murray

  104. Sa1264 A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Centred Pilot Study to Assess the Symptomatic Treatment of Ulcerative Colitis With Cannabidiol

    Article • Gastroenterology, April 2015, Elsevier

    Charles Murray

  105. A rare cause of abdominal pain, diarrhoea and GI bleeding

    Article • Gut, October 2014, BMJ

    Charles Murray

  106. UEG Education: time to shape the future

    Article • United European Gastroenterology Journal, September 2014, SAGE Publications

    Charles Murray

  107. METRIC (MREnterography or ulTRasound in Crohn’s disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in tho...

    Article • BMC Gastroenterology, August 2014, Springer Science + Business Media

    Charles Murray

  108. CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis

    Article • European Journal of Clinical Microbiology & Infectious Diseases, August 2014, Springer Science + Business Media

    Charles Murray

  109. OC-055 Ibd Passport-developing An Evidence-based Internet Travel Resource For Inflammatory Bowel Disease: A Report Of The Initial Stages Of Implementation

    Article • Gut, June 2014, BMJ

    Charles Murray

  110. PTU-092 Patient And Professionals Perceptions Of Travel Behaviour In Inflammatory Bowel Disease

    Article • Gut, June 2014, BMJ

    Charles Murray

  111. PWE-115 Patients Continue To Travel Abroad Despite Recently Active Disease And Travel Concerns: Results Of A Single Centre Study In Inflammatory Bowel Disease And Travel

    Article • Gut, June 2014, BMJ

    Charles Murray

  112. PWE-183 Preliminary Significant Findings From A Randomised Control Trial Of Posterior Tibial Nerve Stimulation In Systemic Sclerosis Associated Faecal Incontinence

    Article • Gut, June 2014, BMJ

    Charles Murray

  113. P574 A recent flare of disease does not prohibit travel: early results of a single centre study in inflammatory bowel disease and travel

    Article • Journal of Crohn s and Colitis, February 2014, Oxford University Press (OUP)

    Charles Murray

  114. P553 A single-centre pilot study examining internet use for health related information among patients with inflammatory bowel disease

    Article • Journal of Crohn s and Colitis, February 2014, Oxford University Press (OUP)

    Charles Murray

  115. Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management

    Article • World Journal of Gastroenterology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Prof james O'Beirne, Charles Murray

  116. Using an ‘action set’ for the management of acute upper gastrointestinal bleeding

    Article • Therapeutic Advances in Gastroenterology, August 2013, SAGE Publications

    Prof james O'Beirne, Charles Murray

  117. Bloody Diarrhoea

    Article • The Lancet, August 2013, Elsevier

    Charles Murray

  118. Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA-based protocol in UK subjects with inflammatory bowel disease suitable for anti-TNFα therapy

    Article • Journal of Crohn s and Colitis, June 2013, Oxford University Press (OUP)

    Charles Murray

  119. PTH-132 Iron Deficiency Anaemia Nurse Led Clinic: Audit of 1st Year

    Article • Gut, June 2013, BMJ

    Charles Murray

  120. P57 Comparative Cost-Effectiveness of IGRA to Detect Latent TB Infection in UK Inflammatory Bowel Disease Patients Initiating Anti-TNFα Agents: Abstract P57 Table 1

    Article • Thorax, November 2012, BMJ

    Charles Murray

  121. Weight loss and lumbosacral back pain in a 79-year-old Indian man

    Article • Gut, October 2012, BMJ

    Charles Murray

  122. Malignant mimicry—a 17-year-old with abdominal pain and weight loss

    Article • Gut, August 2012, BMJ

    Charles Murray

  123. PTU-113 Quality of life in patients with ileoanal pouch: a survey comparing two different patient populations

    Article • Gut, May 2012, BMJ

    Charles Murray

  124. PTU-096 The use of commercial interferon-γ release assays to screen for mycobacterial infection in inflammatory bowel disease patients initiating anti-TNF agents

    Article • Gut, May 2012, BMJ

    Charles Murray

  125. Irritable bowel syndrome

    Article • Medicine, April 2011, Elsevier

    Charles Murray

  126. Influence of smoking and other environmental factors in inflammatory bowel disease activity: what do our patients think?

    Article • Gut, March 2011, BMJ

    Charles Murray

  127. Iron deficiency anaemia is common in patients with an ileoanal pouch and is not always associated with inflammation

    Article • Gut, March 2011, BMJ

    Charles Murray

  128. There will be blood... a complete audit cycle

    Article • Gut, March 2011, BMJ

    Charles Murray, Prof james O'Beirne

  129. Images of the terminal ileum are more convincing than cecal images for verifying the extent of colonoscopy

    Article • Endoscopy, March 2011, Thieme Publishing Group

    Charles Murray

  130. Attitudes and Experiences of Adolescents in an Innovative IBD Transition Service

    Article • Gastrointestinal Nursing, February 2011, Mark Allen Group

    Charles Murray

  131. Amitriptyline modifies the visceral hypersensitivity response to acute stress in the irritable bowel syndrome

    Article • Alimentary Pharmacology & Therapeutics, March 2009, Wiley

    Charles Murray

  132. The effect of Khat (Catha edulis) as an appetite suppressant is independent of ghrelin and PYY secretion

    Article • Appetite, November 2008, Elsevier

    Charles Murray

  133. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease

    Article • Alimentary Pharmacology & Therapeutics, December 2007, Wiley

    Charles Murray

  134. Gastrointestinal Manifestations of Systemic Sclerosis

    Article • Digestive Diseases and Sciences, October 2007, Springer Science + Business Media

    Charles Murray

  135. Pharmacological modulation of gut mucosal and large vessel blood flow

    Article • Alimentary Pharmacology & Therapeutics, January 2007, Wiley

    Charles Murray

  136. Reaping value from intellectual property: DuPont's strategic approach achieves global growth

    Article • Planning Review, January 2007, Emerald

    Charles Murray

  137. Ghrelin augments afferent response to distension in rat isolated jejunum

    Article • Neurogastroenterology & Motility, December 2006, Wiley

    Charles Murray

  138. The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients

    Article • Clinical Nutrition, August 2006, Elsevier

    Charles Murray

  139. Diabetes and the Gastrointestinal System

    Article • March 2006, Wiley

    Charles Murray

  140. Prokineticin-2, motilin, ghrelin and metoclopramide: Prokinetic utility in mouse stomach and colon

    Article • European Journal of Pharmacology, November 2005, Elsevier

    Charles Murray

  141. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study

    Article • Gut, May 2005, BMJ

    Charles Murray

  142. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome

    Article • Gastroenterology, December 2004, Elsevier

    Charles Murray

  143. Sporadic duodenal adenoma is associated with colorectal neoplasia

    Article • Gut, February 2004, BMJ

    Charles Murray

  144. Ghrelin for the gastroenterologist: history and potential

    Article • Gastroenterology, November 2003, Elsevier

    Charles Murray

  145. Biofeedback, not laxatives, improves symptoms, transit and autonomic tone in functional constipation

    Article • Gastroenterology, April 2003, Elsevier

    Charles Murray

  146. Medical management of diverticular disease

    Article • Best Practice & Research Clinical Gastroenterology, August 2002, Elsevier

    Charles Murray

  147. Colonic Disorders

    Article • Wiley

    Charles Murray